These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3289475)

  • 21. [Medical castration in the treatment of locally advanced or metastatic prostate cancer: an update].
    Drouin SJ; Rouprêt M; Davin JL; Soulié M
    Prog Urol; 2009 Apr; 19 Suppl 1():S15-9. PubMed ID: 19465332
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Subcapsular versus total orchiectomy in the treatment of advanced prostate cancer: a randomized trial.
    Roosen JU; Klarskov OP; Mogensen P
    Scand J Urol Nephrol; 2005; 39(6):464-7. PubMed ID: 16303721
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A new surgical technic as a substitute for orchiectomy in the treatment of prostate cancer].
    Romero Maroto J; Verdú Tartajo F
    Actas Urol Esp; 1983; 7(1):7-16. PubMed ID: 6880903
    [No Abstract]   [Full Text] [Related]  

  • 24. The impact of prior radical prostatectomy in men with metastatic castration recurrent prostate cancer: a pooled analysis of 9 Cancer and Leukemia Group B Trials.
    Halabi S; Vogelzang NJ; Ou SS; Small EJ
    J Urol; 2007 Feb; 177(2):531-4. PubMed ID: 17222627
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Controversies in the management of advanced prostate cancer.
    Tyrrell CJ
    Br J Cancer; 1999 Jan; 79(1):146-55. PubMed ID: 10408706
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term followup of a randomized study of locally advanced prostate cancer treated with combined orchiectomy and external radiotherapy versus radiotherapy alone.
    Granfors T; Modig H; Damber JE; Tomic R
    J Urol; 2006 Aug; 176(2):544-7. PubMed ID: 16813885
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of radical prostatectomy in patients with clinically localized prostate cancer and a prostate-specific antigen level >20 ng/ml.
    Bastide C; Kuefer R; Loeffler M; de Petriconi R; Gschwend J; Hautmann R
    Prostate Cancer Prostatic Dis; 2006; 9(3):239-44. PubMed ID: 16832384
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Understanding treatments for bone loss and bone metastases in patients with prostate cancer: a practical review and guide for the clinician.
    Higano CS
    Urol Clin North Am; 2004 May; 31(2):331-52. PubMed ID: 15123412
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cancer of the prostate: subcapsular orchiectomy].
    Cukier J; Rivain T
    Bull Cancer; 1985; 72(6):543-8. PubMed ID: 4092105
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Progressive osteoporosis during androgen deprivation therapy for prostate cancer.
    Daniell HW; Dunn SR; Ferguson DW; Lomas G; Niazi Z; Stratte PT
    J Urol; 2000 Jan; 163(1):181-6. PubMed ID: 10604342
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The technique of apical dissection of the prostate and urethrovesical anastomosis in robotic radical prostatectomy.
    Menon M; Hemal AK; Tewari A; Shrivastava A; Bhandari A
    BJU Int; 2004 Apr; 93(6):715-9. PubMed ID: 15049978
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Periurethral suspension stitch during robot-assisted laparoscopic radical prostatectomy: description of the technique and continence outcomes.
    Patel VR; Coelho RF; Palmer KJ; Rocco B
    Eur Urol; 2009 Sep; 56(3):472-8. PubMed ID: 19560260
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Flutamide versus orchidectomy in the treatment of metastatic prostate carcinoma.
    Boccon-Gibod L; Fournier G; Bottet P; Marechal JM; Guiter J; Rischman P; Hubert J; Soret JY; Mangin P; Mallo C; Fraysse CE
    Eur Urol; 1997; 32(4):391-5; discussion 395-6. PubMed ID: 9412794
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of orchiectomy and various doses of stilbestrol on plasma testosterone levels in patients with carcinoma of the prostate.
    Mackler MA; Liberti JP; Smith MJ; Koontz WW; Prout GR
    Invest Urol; 1972 Mar; 9(5):423-5. PubMed ID: 5016026
    [No Abstract]   [Full Text] [Related]  

  • 35. Characterization of the autochthonous transgenic adenocarcinoma of the mouse prostate (TRAMP) as a model to study effects of castration therapy.
    Wikström P; Lindahl C; Bergh A
    Prostate; 2005 Feb; 62(2):148-64. PubMed ID: 15389804
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Experience in treating advanced prostate cancer with bladder outlet obstruction].
    Sheng XJ; Zhu YJ; Ye M; Chen JH; Zhang L; Kong L
    Ai Zheng; 2005 Oct; 24(10):1284-6. PubMed ID: 16219150
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Surgical treatment of prostate cancer].
    Boccon-Gibod L
    Rev Prat; 1994 Mar; 44(5):601-3. PubMed ID: 7520596
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hot flushes in men after surgical or pharmacologic castration].
    Aubert J; Vigouroux V; Doré B
    Prog Urol; 1995 Sep; 5(4):507-9. PubMed ID: 7581499
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Re: Osteoporosis after orchiectomy for prostate cancer.
    Pavlovich CP; Pitts WR
    J Urol; 1999 Oct; 162(4):1392. PubMed ID: 10492219
    [No Abstract]   [Full Text] [Related]  

  • 40. Castration-induced apoptosis of androgen-dependent shionogi carcinoma is associated with increased expression of genes encoding insulin-like growth factor-binding proteins.
    Nickerson T; Miyake H; Gleave ME; Pollak M
    Cancer Res; 1999 Jul; 59(14):3392-5. PubMed ID: 10416600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.